BSP - Biological Signal Processing
Noninvasive Diagnosis of Cardiac Disease
Company Overview
Snapshot
Founded in January 2000 by Amir Beker, BSP - Biological Signal Processing operates with 1–10 employees. The company specializes in noninvasive diagnosis and monitoring of ischemic heart disease, leveraging its patented high-frequency technology. A significant milestone for the company was its initial public offering on the TASE in May 2006.
Business overview
BSP - Biological Signal Processing develops products for the noninvasive diagnosis and monitoring of ischemic heart disease. The company's core technology is its patented high-frequency HyperQ line of products, which offers solutions for both stress and resting ECG tests. These products are designed to improve the diagnosis of coronary artery disease and detect acute coronary syndrome in emergency settings. BSP serves the healthcare industry, particularly clinics, hospitals, and healthcare providers, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Diagnostics Devices.
Strategic signal
In July 2018, BSP Medical participated in a medical delegation to India, indicating a strategic focus on international market expansion and engagement. This move suggests the company was actively exploring new opportunities for its noninvasive cardiac diagnostic technologies in emerging markets, aiming to broaden its commercial reach and validate its solutions on a global scale.
Log in to access full profile ›Company Intelligence Q&A
- When did BSP - Biological Signal Processing go public?
- BSP - Biological Signal Processing completed an Initial Public Offering (IPO) on the TASE in May 2006.
- What is the status of BSP - Biological Signal Processing?
- BSP - Biological Signal Processing became non-active in May 2018, following its delisting from the TASE.
- Has BSP - Biological Signal Processing expanded its market reach internationally?
- In July 2018, BSP Medical announced its participation in a medical delegation to India, indicating efforts to explore international market opportunities.
- What is the HyperQ technology used for?
- The HyperQ technology is used for both stress ECG tests and resting ECG tests to significantly enhance the diagnostic value for detecting ischemia and acute coronary syndrome.